Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners, announced today the acquisition of Mosaic Laboratories LLC, a California-based company offering histology and immunohistochemistry services to global pharmaceutical clients.
Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners, announced today the acquisition of Clinical Logistics Inc. ("CLI"), a Virtual Central Specimen Management CRO based in Halifax, Canada.
Arsenal Capital Partners, a private equity firm that specializes in investments in healthcare and specialty industrial companies, has acquired Best Value Healthcare LLC in partnership with its founders: Raj Naik, M.D., Kimberly Ficocelli, and Dillon Moore. Best Value is a leading primary care platform focused on Medicare Advantage and operating in Central and South Florida. The terms of the transaction were not disclosed.
symplr, a leading global healthcare governance, risk management, and compliance software-as-a-service platform, backed by Clearlake Capital Group, L.P. and SkyKnight Capital, today announced that it has signed a definitive agreement to acquire TractManager from Arsenal Capital Partners.
Arsenal Capital Partners, a private equity firm that specializes in investments in healthcare and industrial companies, today announced its partnership with Dr. Richard Eglen as a Senior Advisor to its healthcare team. Dr. Eglen will work with Arsenal’s healthcare team to further develop life science tools and reagents investment themes. He will also serve as both a member of the Scientific Advisory Board and an advisor to the Board of Directors of BioIVT, an Arsenal portfolio company that is a global leader in providing in vitro research models and services for drug and diagnostic development.
Arsenal Capital Partners is a specialized private equity firm with a deep focus in two sectors, Specialty Industrials and Healthcare. Our philosophy is to partner with talented management teams, provide them with access to world-class operating resources and patient capital, and develop positive, open and constructive relationships that foster long-term value creation.